Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 1/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | XBP1 | P17861 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6448541 | 1.00 | EPHX2 (0.35) | EPHX2PRKCACYP17A1CYP19A1TSHR | |
| SCHEMBL18133301 | 1.00 | EPHX2 (0.35) | EPHX2PRKCACYP17A1CYP19A1TSHR | |
| SCHEMBL22797667 | 0.92 | EPHX2 (0.33) | EPHX2PRKCACYP17A1CYP19A1TSHR | |
| SCHEMBL2130379 | 0.91 | CYP17A1 (0.32) | PRKCACYP17A1CYP19A1TSHRNPSR1 | |
| SCHEMBL19042387 | 0.90 | EPHX2 (0.33) | EPHX2PRKCACYP17A1CYP19A1TSHR | |
| SCHEMBL26190812 | 0.90 | CYP17A1 (0.35) | EPHX2PRKCACYP17A1CYP19A1TSHR | |
| SCHEMBL26190682 | 0.88 | CYP17A1 (0.34) | EPHX2PRKCACYP17A1CYP19A1TSHR | |
| SCHEMBL17578294 | 0.88 | PRKCA (0.42) | PRKCACYP17A1CYP19A1NPSR1GAA | |
| SCHEMBL75500 | 0.88 | PRKCA (0.42) | PRKCACYP17A1CYP19A1NPSR1GAA | |
| SCHEMBL14479483 | 0.88 | PRKCA (0.42) | PRKCACYP17A1CYP19A1NPSR1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210188770-A1 | ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210188770-A1 | ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SLC6A5, LIFR, SLC6A9 | EPHX2 3804/4885PRKCA 2943/4885CYP17A1 1460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.